<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03110562</url>
  </required_header>
  <id_info>
    <org_study_id>KCP-330-023</org_study_id>
    <nct_id>NCT03110562</nct_id>
  </id_info>
  <brief_title>Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma</brief_title>
  <acronym>BOSTON</acronym>
  <official_title>A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karyopharm Therapeutics Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karyopharm Therapeutics Inc</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Phase 3, 2-arm, randomized, active comparator-controlled, open-label, multicenter study
      will compare the efficacy and health-related quality of life (HR-QoL) and assess the safety
      of selinexor plus bortezomib (Velcade®) plus low-dose dexamethasone (SVd) versus bortezomib
      plus low-dose dexamethasone (Vd) in adult patients with RRMM who have received 1 to 3 prior
      anti-multiple myeloma (MM) regimens. Crossover from the Vd Arm to a treatment that includes
      selinexor (i.e., SVdX or SdX) will be allowed at the point of IRC-confirmed objective disease
      progression per the IMWG criteria for patients in the Vd Arm.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 7, 2017</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare progression-free survival (PFS) based on the Independent Review Committee's (IRC's) disease outcome assessments in patients randomized to the SVd Arm versus the Vd Arm</measure>
    <time_frame>15 months</time_frame>
    <description>PFS, defined as time from date of randomization until the first date of PD, per International Myeloma Working Group (IMWG) response criteria, or death due to any cause, whichever occurs first. For the purposes of PFS determination, PD will be determined by the IRC.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare the overall response rate (ORR) based on the IRC's response outcome assessments in patients randomized to the SVd Arm versus the Vd Arm</measure>
    <time_frame>15 months</time_frame>
    <description>ORR, defined as any response ≥ PR based on the IRC's response outcome assessments, according to the IMWG response criteria</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">364</enrollment>
  <condition>Multiple Myeloma</condition>
  <arm_group>
    <arm_group_label>selinexor+bortezomib+dexamethasone (SVd)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Selinexor will be given on Days 1, 8, 15, 22, and 29 of each 35-day cycle. Bortezomib will be given Days 1, 8, 15, and 22 of each 35-day cycle. Dexamethasone will be given Days 1, 2, 8, 9, 15, 16, 22, 23, 29, and 30 of each 35-day cycle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bortezomib+dexamethasone (Vd)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bortezomib will be given Days 1, 4, 8, and 11 of each 21-day cycle for the first 8 cycles. For Cycles ≥ 9, bortezomib will be given on Days 1, 8, 15, and 22 of each 35-day cycle. Dexamethasone will be given on Days 1, 2, 4, 5, 8, 9, 11, and 12 of each 21-day cycle for the first 8 cycles. For Cycles ≥ 9, dexamethasone will be given on Days 1, 2, 8, 9, 15, 16, 22, 23, 29, and 30 of each 35-day cycle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Selinexor</intervention_name>
    <description>oral 100 mg dose</description>
    <arm_group_label>selinexor+bortezomib+dexamethasone (SVd)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bortezomib</intervention_name>
    <description>subcutaneous dose of 1.3 mg/m2</description>
    <arm_group_label>selinexor+bortezomib+dexamethasone (SVd)</arm_group_label>
    <arm_group_label>bortezomib+dexamethasone (Vd)</arm_group_label>
    <other_name>Velcade®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>oral dose of 20mg</description>
    <arm_group_label>selinexor+bortezomib+dexamethasone (SVd)</arm_group_label>
    <arm_group_label>bortezomib+dexamethasone (Vd)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Histologically confirmed MM with measurable disease per IMWG guidelines as defined by
             at least 1 of the following:

               1. Serum M-protein ≥ 0.5 g/dL (&gt; 5 g/L) by serum protein electrophoresis (SPEP) or
                  for immunoglobulin (Ig) A myeloma, by quantitative serum IgA levels; or

               2. Urinary M-protein excretion at least 200 mg/24 hours; or

               3. Serum free light chain (FLC) ≥ 100 mg/L, provided that the serum FLC ratio is
                  abnormal.

          2. Had at least 1 prior anti-MM regimen and no more than 3 prior anti-MM regimens.
             Induction therapy followed by stem cell transplant and consolidation/maintenance
             therapy will be considered as 1 anti-MM regimen.

          3. Documented evidence of progressive MM (based on the Investigator's determination
             according to the modified IMWG response criteria) on or after their most recent
             regimen.

          4. Prior treatment with bortezomib or other Proteasome Inhibitor (PI) is allowed,
             provided all of the following criteria are met:

             Best response achieved with prior bortezomib at any time was ≥ PR and with the last PI
             (PI therapy (alone or in combination) was ≥ PR, AND Participant did not discontinue
             bortezomib due to ≥ Grade 3 related toxicity, AND Must have had at least a 6-month
             PI-treatment-free interval prior to Cycle 1 Day 1 (C1D1) of study treatment.

          5. Resolution of any clinically significant non-hematological toxicities (if any) from
             previous treatments to ≤ Grade 1 by C1D1.

          6. Adequate hepatic function within 28 days prior to C1D1

          7. Adequate renal function within 28 days prior to C1D1

          8. Adequate hematopoietic function within 7 days prior to C1D1

        Exclusion Criteria:

          1. Prior exposure to a SINE compound (i.e. an XPO-1 inhibitor), including selinexor.

          2. Prior malignancy that required treatment, or has shown evidence of recurrence (except
             for non-melanoma skin cancer or adequately treated cervical carcinoma in situ) during
             the 5 years prior to randomization.

          3. Any concurrent medical condition or disease (e.g., uncontrolled active hypertension,
             uncontrolled active diabetes, active systemic infection, etc.) that is likely to
             interfere with study procedures.

          4. Uncontrolled active infection requiring parenteral antibiotics, antivirals, or
             antifungals within 1 week prior to C1D1.

          5. Active plasma cell leukemia.

          6. Documented systemic light chain amyloidosis.

          7. MM involving the central nervous system.

          8. Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes
             (POEMS) syndrome.

          9. Spinal cord compression.

         10. Greater than Grade 2 neuropathy or ≥ Grade 2 neuropathy with pain at baseline,
             regardless of whether or not the patient is currently receiving medication

         11. Known intolerance, hypersensitivity, or contraindication to glucocorticoids.

         12. Radiation, chemotherapy, or immunotherapy or any other anticancer therapy (including
             investigational therapies) ≤ 2 weeks prior to C1D1. Localized radiation to a single
             site at least 1 week before C1D1 is permitted. Glucocorticoids within 2 weeks of C1D1
             are permitted. Patients on long-term glucocorticoids during Screening do not require a
             washout period but must be able to tolerate the specified dexamethasone dose in this
             study.

         13. Prior autologous stem cell transplantation &lt; 1 month or allogeneic stem cell
             transplantation &lt; 4 months prior to C1D1.

         14. Active graft versus host disease (after allogeneic stem cell transplantation) at C1D1.

         15. Pregnant or breastfeeding females.

         16. Body Surface Area &lt; 1.4 m2 at baseline, calculated by the Dubois or Mosteller method.

         17. Life expectancy of &lt; 4 months.

         18. Major surgery within 4 weeks prior to C1D1.

         19. Active, unstable cardiovascular function:

               1. Symptomatic ischemia, or

               2. Uncontrolled clinically significant conduction abnormalities (e.g., patients with
                  ventricular tachycardia on anti-arrhythmics are excluded; patients with
                  first-degree atrioventricular block or asymptomatic left anterior fascicular
                  block/right bundle branch block will not be excluded), or

               3. Congestive heart failure of New York Heart Association Class ≥ 3 or known left
                  ventricular ejection fraction &lt; 40%, or

               4. Myocardial infarction within 3 months prior to C1D1.

         20. Known active human immunodeficiency virus (HIV) infection or HIV seropositivity

         21. Known active hepatitis A, B, or C infection; or known to be positive for hepatitis C
             virus ribonucleic acid (RNA) or hepatitis B virus surface antigen.

         22. Active gastrointestinal dysfunction interfering with the patient's ability to swallow
             tablets, or any active gastrointestinal dysfunction that could interfere with
             absorption of study treatment.

         23. Any active, serious psychiatric, medical, or other conditions/situations that, in the
             opinion of the Investigator, could interfere with treatment, compliance, or the
             ability to give informed consent.

         24. Contraindication to any of the required concomitant drugs or supportive treatments.

         25. Patients unwilling or unable to comply with the protocol, including providing 24-hour
             urine samples for urine protein electrophoresis at the required time points.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Kauffman, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Karyopharm Therapeutics Inc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Kauffman, MD, PhD</last_name>
    <phone>(617) 658-0600</phone>
    <email>MKauffman@Karyopharm.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sharon Shacham, PhD</last_name>
    <phone>(617) 658-0600</phone>
    <email>SShacham@Karyopharm.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boca Raton Clinical Research (BRCR) Medical Center</name>
      <address>
        <city>Plantation</city>
        <state>Florida</state>
        <zip>33324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Tache, DO</last_name>
      <email>jasontache@brcrglobal.com</email>
    </contact>
    <investigator>
      <last_name>Jason Tache, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ajay Nooka, MD, MPH, FACP</last_name>
      <email>anooka@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Ajay Nooka, MD, MPH, FACP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Hawaii</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennnifer Carney, MD</last_name>
      <email>jennifer.f.carney@kp.org</email>
    </contact>
    <investigator>
      <last_name>Jennnifer Carney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McFarland Clinic</name>
      <address>
        <city>Ames</city>
        <state>Iowa</state>
        <zip>50010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra Prow, MD</last_name>
      <email>dprow@mcfarlandclinic.com</email>
    </contact>
    <investigator>
      <last_name>Debra Prow, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stormont Vail Health Care (Cotton O'Neil Cancer Center )</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muhammad Salamat, MD, MBSS</last_name>
      <email>msalamat@stormontvail.org</email>
    </contact>
    <investigator>
      <last_name>Muhammad Salamat, MD, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Commonwealth Hematology</name>
      <address>
        <city>Danville</city>
        <state>Kentucky</state>
        <zip>40422</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Nidhiry, MD</last_name>
      <email>enidhiry@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Emmanuel Nidhiry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Norton Cancer Institute</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Don Stevens, MD</last_name>
      <email>Don.Stevens@nortonhealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Don Stevens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashraf Badros, M.D., M.B., Ch.B.</last_name>
      <email>abadros@umm.edu</email>
    </contact>
    <investigator>
      <last_name>Ashraf Badros, M.D., M.B., Ch.B.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Care Cancer Center</name>
      <address>
        <city>Bolivar</city>
        <state>Missouri</state>
        <zip>65613</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leonid Shunyakov, MD</last_name>
      <email>drleo@cccancer.com</email>
    </contact>
    <investigator>
      <last_name>Leonid Shunyakov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Catholic Health Institute St. Francis</name>
      <address>
        <city>Grand Island</city>
        <state>Nebraska</state>
        <zip>68803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mehmet Copur, M.D. F.A.C.P.</last_name>
      <email>mcopur@sfmc-gi.org</email>
    </contact>
    <investigator>
      <last_name>Mehmet Copur, M.D. F.A.C.P.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Valley Hospital Luckow Pavilion</name>
      <address>
        <city>Paramus</city>
        <state>New Jersey</state>
        <zip>07652</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jason Suh</last_name>
      <email>jsuh@valleyhealth.com</email>
    </contact>
    <investigator>
      <last_name>Jason Suh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sundar Jagannath, MD</last_name>
      <email>sundar.jagannath@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Sundar Jagannath, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Cancer Institute at St. Francis Hospital</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dilip Patel, MD</last_name>
    </contact>
    <investigator>
      <last_name>Dilip Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Novant-Forsyth Memorial Hospital</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franklin Chen, MD</last_name>
      <email>flchen@novanthhealth.org</email>
    </contact>
    <investigator>
      <last_name>Franklin Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Health</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tahir Latif, MBBS MBA FACP</last_name>
      <email>tahir.latif@uc.edu</email>
    </contact>
    <investigator>
      <last_name>Tahir Latif, MBBS MBA FACP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southwest Cancer Center of Oklahoma</name>
      <address>
        <city>Lawton</city>
        <state>Oklahoma</state>
        <zip>73505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Najera, MD</last_name>
      <email>eugenio.najera@ccswok.org</email>
    </contact>
    <investigator>
      <last_name>Jose Najera, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Northwest OR</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abdul Hai Mansoor, MD</last_name>
      <email>abdul-hai.mansoor@kp.org</email>
    </contact>
    <investigator>
      <last_name>Abdul Hai Mansoor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SCOR AnMed Health Cancer Center</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Doster, MD</last_name>
      <email>jedoster@bellsouth.net</email>
    </contact>
    <investigator>
      <last_name>John Doster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prairie Lakes Healthcare</name>
      <address>
        <city>Watertown</city>
        <state>South Dakota</state>
        <zip>57201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bipinkumar Amin, MD, MBBS</last_name>
      <email>bipin.amin@prairielakes.com</email>
    </contact>
    <investigator>
      <last_name>Bipinkumar Amin, MD, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Sammons Cancer Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moshe Levy, MD</last_name>
      <email>Moshe.levy@baylorhealth.edu</email>
    </contact>
    <investigator>
      <last_name>Moshe Levy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Larry Anderson, MD, PhD</last_name>
      <email>larry.anderson@utsw.edu</email>
    </contact>
    <investigator>
      <last_name>Larry Anderson, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Hospital Sydney</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nada Hamad, MBBS FRACP FRCPA</last_name>
      <email>Nada.Hamad@svha.org.au</email>
    </contact>
    <investigator>
      <last_name>Nada Hamad, MBBS FRACP FRCPA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Calvary Mater Newcastle</name>
      <address>
        <city>Waratah</city>
        <state>New South Wales</state>
        <zip>5042</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janowski, FRACP, B Med, BSc</last_name>
      <phone>61 2 4014 3028</phone>
      <email>Wojt.Janowski@calvarymater.org.au</email>
    </contact>
    <investigator>
      <last_name>Wojciech Janowski, FRACP, B Med, BSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Women's Hospital</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Butler, MBBS FRACP FRCPA M.Med Sci</last_name>
      <email>jason.butler@health.qld.gov.au</email>
    </contact>
    <investigator>
      <last_name>Jason Butler, MBBS FRACP FRCPA M.Med Sci</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mater Misericordiae Limited and Mater Medical Research</name>
      <address>
        <city>South Brisbane</city>
        <state>Queensland</state>
        <zip>4101</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naadir Gutta, MBBCh FRACP FRCPA</last_name>
      <email>naadir.gutta@mater.org.au</email>
    </contact>
    <investigator>
      <last_name>Naadir Gutta, MBBCh FRACP FRCPA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gold Coast University Hospital</name>
      <address>
        <city>Southport</city>
        <state>Queensland</state>
        <zip>4215</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Bryson, MBChB MRCP FRCPath FRCPA FRCAP</last_name>
      <email>Michelle.Bryson@health.qld.gov.au</email>
    </contact>
    <investigator>
      <last_name>Michelle Bryson, MBChB MRCP FRCPath FRCPA FRCAP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Noemi Horvath, MD FRACP FRCPA</last_name>
      <email>noemi.horvath@sa.gov.au</email>
    </contact>
    <investigator>
      <last_name>Noemi Horvath, MD FRACP FRCPA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Flinders Medical Centre</name>
      <address>
        <city>Bedford Park</city>
        <state>South Australia</state>
        <zip>5042</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Craig Wallington-Beddoe, MBBS PhD FRACP FRCPA</last_name>
      <email>Craig.Wallington-Beddoe@sa.gov.au</email>
    </contact>
    <investigator>
      <last_name>Craig Wallington-Beddoe, MBBS PhD FRACP FRCPA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Hospital Melbourne</name>
      <address>
        <city>Fitzroy</city>
        <state>Victoria</state>
        <zip>3065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hang Quach, MBBS SpecCertOC FRACP FRCPA MD</last_name>
      <email>hang.quach@svha.org.au</email>
    </contact>
    <investigator>
      <last_name>Hang Quach, MBBS SpecCertOC FRACP FRCPA MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Spencer, MBBS FRACP FRCPA</last_name>
      <email>a.spencer@alfred.org.au</email>
    </contact>
    <investigator>
      <last_name>Andrew Spencer, MBBS FRACP FRCPA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University Innsbruck, Department of Internal Medicine V (Hematology and Oncology)</name>
      <address>
        <city>Innsbruck</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eberhard Gunsilius, MD</last_name>
    </contact>
    <investigator>
      <last_name>Eberhard Gunsilius, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Krems, Department of Internal Medicine II</name>
      <address>
        <city>Krems</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus Podar, MD, Msc, PhD</last_name>
      <email>Klaus.Podar@krems.lknoe.at</email>
    </contact>
    <investigator>
      <last_name>Klaus Podar, MD, Msc, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria-Theresa Krauth, Dr.</last_name>
      <email>maria.krauth@meduniwien.ac.at</email>
    </contact>
    <investigator>
      <last_name>Maria-Theresa Krauth, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital Hietzing</name>
      <address>
        <city>Vienna</city>
        <zip>1130</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus Geissler, MD</last_name>
      <email>forschung.hietzing@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Klaus Geissler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wilhelminen Hospital, Department of Internal Medicne I, Center for Oncology &amp; Hematology</name>
      <address>
        <city>Vienna</city>
        <zip>1160</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabine Burger, MD</last_name>
      <email>sabine.burger@wienkav.at</email>
    </contact>
    <investigator>
      <last_name>Sabine Burger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jules Bordet Institute</name>
      <address>
        <city>Brussels</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Meuleman, MD</last_name>
      <email>nathalie.meuleman@bordet.be</email>
    </contact>
    <investigator>
      <last_name>Nathalie Meuleman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCL Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Christiane Vekemans, MD</last_name>
      <email>marie-christiane.vekemans@uclouvain.be</email>
    </contact>
    <investigator>
      <last_name>Marie-Christiane Vekemans, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Vlummens, MD</last_name>
      <email>Philip.Vlummens@uzgent.be</email>
    </contact>
    <investigator>
      <last_name>Philip Vlummens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital Delta</name>
      <address>
        <city>Roeselare</city>
        <zip>8800</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dries Deeren, MD</last_name>
      <email>driesdeeren@skynet.be</email>
    </contact>
    <investigator>
      <last_name>Dries Deeren, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Augustinus Hospital</name>
      <address>
        <city>Wilrijk</city>
        <zip>2610</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Lemmens, MD</last_name>
      <email>Jan.Lemmens@GZA.BE</email>
    </contact>
    <investigator>
      <last_name>Jan Lemmens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mont-Godinne University Hospital</name>
      <address>
        <city>Yvoir</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chantal Doyen, MD</last_name>
      <email>chantal.doyen@uclouvain.be</email>
    </contact>
    <investigator>
      <last_name>Chantal Doyen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital for Active Treatment, Sveti Georgi Clinic of Clinical Hematology</name>
      <address>
        <city>Plovdiv</city>
        <zip>4002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vesselina Goranova-Marinova, MD</last_name>
      <email>vesselina_goranova@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Vesselina Goranova-Marinova, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital for Active Treatment, Sveti Ivan Rilski Clinic of Hematology</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Atanas Radinoff, MD</last_name>
      <email>aradinoff@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Atanas Radinoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Specialized Hospital for Active Treatment of Hematological Diseases, Clinic of Hematology, Dept. of Clinical Hematology</name>
      <address>
        <city>Sofia</city>
        <zip>1756</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Branimir Spassov, MD</last_name>
      <email>branispassov@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Branimir Spassov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tom Baker Cancer Center/ Alberta Health Services</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4Z6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nizar Bahlis, MD</last_name>
      <email>nbahlis@ucalgary.ca</email>
    </contact>
    <investigator>
      <last_name>Nizar Bahlis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cross Cancer Institute / University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 1Z2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Venner, MD</last_name>
      <email>ChristopherPaul.Venner@albertahealthservices.ca</email>
    </contact>
    <investigator>
      <last_name>Chris Venner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Sutherland, MD, PhD, FRCPC</last_name>
      <email>hsutherl@bccancer.bc.ca</email>
    </contact>
    <investigator>
      <last_name>Heather Sutherland, MD, PhD, FRCPC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth II Health Sciences Center</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 2Y9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darrell White, MD, MSc, FRCPC, FACP</last_name>
      <email>Darrell.White@nshealth.ca</email>
    </contact>
    <investigator>
      <last_name>Darrell White, MD, MSc, FRCPC, FACP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Cancer Research</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Reece, MD</last_name>
      <email>Donna.Reece@uhn.edu</email>
    </contact>
    <investigator>
      <last_name>Donna Reece, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maisonneuve-Rosemont Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard LeBlanc, M.D., FRCPC</last_name>
      <email>rleblanc.hmr@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Richard LeBlanc, M.D., FRCPC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Hospital / McGill University</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Sebag</last_name>
      <email>michael.sebag@mcgill.ca</email>
    </contact>
    <investigator>
      <last_name>Michael Sebag, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>L'Hôtel-Dieu de Québec</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <zip>G1R 2J6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Lalancette, MD</last_name>
      <email>marclalancette@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Marc Lalancette, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saskatchewan Cancer Agency-Allan Blair Cancer Centre</name>
      <address>
        <city>Regina</city>
        <state>Saskatchewan</state>
        <zip>S4T 7TI</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haji Chalchal, MD</last_name>
      <email>haji.chalchal@saskcancer.ca</email>
    </contact>
    <investigator>
      <last_name>Haji Chalchal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saskatoon Cancer Center</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7N 4H4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Waleed Sabry, MD</last_name>
      <email>Waleed.Sabry@saskcancer.ca</email>
    </contact>
    <investigator>
      <last_name>Waleed Sabry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General University Hospital in Prague</name>
      <address>
        <city>Praha 2</city>
        <state>Prague</state>
        <zip>128 08</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivan Spicka, M.D., Ph.D.</last_name>
      <email>spicka@cesnet.cz</email>
    </contact>
    <investigator>
      <last_name>Ivan Spicka, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hopsital Brno</name>
      <address>
        <city>Brno</city>
        <zip>625 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ludek Pour, MUDr., Ph.D.</last_name>
      <email>pour.ludek@fnbrno.cz</email>
    </contact>
    <investigator>
      <last_name>Ludek Pour, MUDr., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Hradec Kralove</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>500 05</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir Maisnar, MD, PhD, MBA</last_name>
      <email>maisnar@fnhk.cz</email>
    </contact>
    <investigator>
      <last_name>Vladimir Maisnar, MD, PhD, MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Olomouc</name>
      <address>
        <city>Olomouc</city>
        <zip>775 20</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiri Minarik, MUDr., PhD</last_name>
      <email>abretina@email.cz</email>
    </contact>
    <investigator>
      <last_name>Jiri Minarik, MUDr., PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Ostrava, Dept. of Hematooncology</name>
      <address>
        <city>Ostrava</city>
        <zip>708 52</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roman Hajek, M.D. Ph.D.</last_name>
      <email>roman.hajek@fno.cz</email>
    </contact>
    <investigator>
      <last_name>Roman Hajek, M.D. Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Kralovske Vinohrady, Clinic of Internal Hematology</name>
      <address>
        <city>Prague</city>
        <zip>100 34</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petr Pavlicek, MUDr.</last_name>
      <email>petr.pavlicek@fnkv.cz</email>
    </contact>
    <investigator>
      <last_name>Petr Pavlicek, MUDr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Necker Children's Hospital, Department of Adult Hematology</name>
      <address>
        <city>Paris</city>
        <state>Ile De France</state>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Frenzel, M.D., Ph.D.</last_name>
      <email>laurent.frenzel@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Laurent Frenzel, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Center of Basque Coast</name>
      <address>
        <city>Bayonne</city>
        <zip>64100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carla Araujo, M.D.</last_name>
      <email>caraujo@ch-cotebasque.fr</email>
    </contact>
    <investigator>
      <last_name>Carla Araujo, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Center Departmental La Roche-Sur-Yon</name>
      <address>
        <city>La Roche-sur-Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mourad Tiab, M.D.</last_name>
      <email>Mourad.tiab@chd-vendee.fr</email>
    </contact>
    <investigator>
      <last_name>Mourad Tiab, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Claude Huriez Hospital</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry Facon, Pr.</last_name>
      <email>t-facon@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Thierry Facon, Pr..</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Lyon Hospital Center</name>
      <address>
        <city>Lyon</city>
        <zip>69002</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lionel Karlin, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Lionel Karlin, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brabois Adults Hospital, University Hospital Center of Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurore Perrot, MD, PhD</last_name>
      <email>au.perrot@chru-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Aurore Perrot, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital Center</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Moreau, MD, PhD</last_name>
      <email>philippe.moreau@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe Moreau, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint-Louis Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand Arnulf, M.D.</last_name>
      <email>bertrand.arnulf@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Bertrand Arnulf, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Miletrie Hospital, University Hospital Center of Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Leleu, M.D., Ph.D.</last_name>
      <email>Xavier.leleu@chu-poitiers.fr</email>
    </contact>
    <investigator>
      <last_name>Xavier Leleu, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Freiburg, Department of Internal Medicine I</name>
      <address>
        <city>Freiburg</city>
        <state>Baden-Wuerttemberg</state>
        <zip>D-79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monika Engelhardt</last_name>
      <phone>0049 761 270 32460</phone>
      <email>monika.engelhardt@uniklinik-freiburg.de</email>
    </contact>
    <contact_backup>
      <last_name>, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Monika Engelhardt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Leverkusen gGmbH Medizinisxhe Klinik 3</name>
      <address>
        <city>Leverkusen</city>
        <state>North Rhine Westfalia</state>
        <zip>51375</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dagmar Sent, Dr. med.</last_name>
      <email>dagmar.sent@klinikum-lev.de</email>
    </contact>
    <investigator>
      <last_name>Dagmar Sent, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Saarland, Department of INternal Medicine I</name>
      <address>
        <city>Homburg/Saar</city>
        <state>Saarland</state>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nichole Adrian, Dr. med.</last_name>
      <email>nicole.adrian@uniklinikum-saarland.de</email>
    </contact>
    <investigator>
      <last_name>Nichole Adrian, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Group Practice for Hematology and Oncology</name>
      <address>
        <city>Dresden</city>
        <state>Saxony</state>
        <zip>1307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Illmer, PD Dr. med. habil.</last_name>
      <email>illmer@onkologie-dresden.net</email>
    </contact>
    <investigator>
      <last_name>Thomas Illmer, PD Dr. med. habil.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alexandra General Hospital, Therapeutic Clinic</name>
      <address>
        <city>Athens</city>
        <zip>11528</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meletios-Athanasios Dimopoulos, MD</last_name>
      <phone>(+) 30 697 731 19 99</phone>
      <email>mdimop@med.uoa.gr</email>
    </contact>
    <investigator>
      <last_name>Meletios-Athanasios Dimopoulos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital of Athens &quot;Evangelismos&quot;, Department of Hematology and Lymphoma</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sosana Delimpasi, MD</last_name>
      <email>sodeli@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Sosana Delimpasi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Iaso Thessalias</name>
      <address>
        <city>Larisa</city>
        <zip>41500</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>George Karamarias, MD</last_name>
      <email>gskaramarias@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>George Karamarias, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University General Hospital of Patra</name>
      <address>
        <city>Pátra</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anargyros Symeonidis, MD</last_name>
      <email>argiris.symeonidis@yahoo.gr</email>
    </contact>
    <investigator>
      <last_name>Anargyros Symeonidis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Theageneion Cancer Hospital, Hematology Department</name>
      <address>
        <city>Thessaloníki</city>
        <zip>54639</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eirini Katodritou, MD, PhD</last_name>
      <email>eirinikatodritou@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Eirini Katodritou, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Semmelweis University, 1st Department of Internal Medicine</name>
      <address>
        <city>Budapest</city>
        <zip>H-1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zsolt Nagy, MD, PhD</last_name>
      <email>nagy.zsolt@med.semmelweis-univ.hu</email>
    </contact>
    <investigator>
      <last_name>Zsolt Nagy, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Integrated Szent Istvan and Szent laszlo Hospital, Department of Hematology and Stem Cell Transplantation</name>
      <address>
        <city>Budapest</city>
        <zip>H-1097</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabor Mikala, MD PhD</last_name>
      <email>gmikala@laszlokorhaz.hu</email>
    </contact>
    <investigator>
      <last_name>Gabor Mikala, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Semmelweis University, 3rd Department of Internal Medicine</name>
      <address>
        <city>Budapest</city>
        <zip>H-1125</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tamas Masszi, MD PhD</last_name>
      <email>masszi.tamas@med.semmelweis-univ.hu</email>
    </contact>
    <investigator>
      <last_name>Tamas Masszi, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaposi Mor Teaching Hospital, 2nd Department of Internal Medicine</name>
      <address>
        <city>Kaposvar</city>
        <zip>7400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Miklos Egyed, MD PhD Med habil Prof</last_name>
      <email>dregyedmiklos@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Miklos Egyed, MD PhD Med habil Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical Center of the University of Pecs, Department of Hematology</name>
      <address>
        <city>Pecs</city>
        <zip>7624</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hussain Alizadeh, MD, PhD</last_name>
      <email>alizadeh.hussain@pte.hu</email>
    </contact>
    <investigator>
      <last_name>Hussain Alizadeh, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regional Cancer Centre</name>
      <address>
        <city>Patna</city>
        <state>Bihar</state>
        <zip>800014</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dinesh Kumar Sinha, MBBS MD</last_name>
      <email>drdineshkumarsinha@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Dinesh Kumar Sinha, MBBS MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regional Cancer Centre</name>
      <address>
        <city>Thiruvananthapuram</city>
        <state>Kerala</state>
        <zip>695011</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sreejith Nair, MBBS DMRT DM</last_name>
      <email>sreejith.sg@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Sreejith Nair, MBBS DMRT DM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prince Aly Khan Hospital</name>
      <address>
        <city>Mumbai</city>
        <state>Maharesh</state>
        <zip>400010</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tapan Saikia, MBBS, MD</last_name>
      <email>tapan.saikia@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Tapan Saikia, MBBS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jaslok Hospital and Research Centre</name>
      <address>
        <city>Mumbai</city>
        <state>Maharesh</state>
        <zip>400026</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Suresh Advani, MBBS, MD</last_name>
      <email>shadvani2000@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Suresh Advani, MBBS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ruby Hall Clinic</name>
      <address>
        <city>Pune</city>
        <state>Maharesh</state>
        <zip>411001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Minish Jain, MD, MBBS</last_name>
      <email>drminishjain@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Minish Jain, MD, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IMS Hospital</name>
      <address>
        <city>Bhubaneswar</city>
        <state>Odisha</state>
        <zip>751003</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sourav Kumar Mishra, MBBS MD DM</last_name>
      <email>drskmishra1984@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Sourav Kumar Mishra, MBBS MD DM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Postgraduate Institute of Medical Education &amp; Research (PGIMER)</name>
      <address>
        <city>Chandigarh</city>
        <state>Punjab</state>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pankaj Malhotra, MD MBBS</last_name>
      <email>malhotra.pankaj@pgimer.edu.in</email>
    </contact>
    <investigator>
      <last_name>Pankaj Malhotra, MD MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dayanand Medical College &amp; Hospital</name>
      <address>
        <city>Ludhiana</city>
        <state>Punjab</state>
        <zip>141001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Davinder Paul, DM, MBBS, MD</last_name>
      <email>Davinder5858@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Davinder Paul, DM, MBBS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cancer Institute</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <zip>600020</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prasanth Ganesan, DM MD MBBS</last_name>
      <email>pg1980@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Prasanth Ganesan, DM MD MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SRM Institute of Medical Sciences</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <zip>600026</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ranjan Mohapatra, MBBS DM DM (Oncology)</last_name>
      <email>drranjan.km@simshospitals.com</email>
    </contact>
    <investigator>
      <last_name>Ranjan Mohapatra, MBBS DM DM (Oncology)</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saveetha Medical College Hospital</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <zip>602105</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita Ramesh, MBBS MD DNB DM DCH M.Sc</last_name>
      <email>anitachandra100@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Anita Ramesh, MBBS MD DNB DM DCH M.Sc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>G. Kuppuswamy Naidu Hospital</name>
      <address>
        <city>Coimbatore</city>
        <state>Tamil Nadu</state>
        <zip>641037</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Balasubramanian Sivanesan, DM MD MBBS</last_name>
      <email>bsivanesan@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Balasubramanian Sivanesan, DM MD MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asviratham Speciality Hospital</name>
      <address>
        <city>Madurai</city>
        <state>Tamil Nadu</state>
        <zip>625020</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Jebasingh, DM DNB MD MBBS</last_name>
      <email>jjebasingh@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Joseph Jebasingh, DM DNB MD MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Meenakshi Mission Hospital</name>
      <address>
        <city>Madurai</city>
        <state>Tamil Nadu</state>
        <zip>625107</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krishna Kumar Rathnam, DM MD MBBS</last_name>
      <email>kkrathnam@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Krishna Kumar Rathnam, DM MD MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yashoda Hospital</name>
      <address>
        <city>Hyderabad</city>
        <state>Telengana</state>
        <zip>500082</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ganesh Jaishetwar</last_name>
      <email>ganeshjaishetwar@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ganesh Jaishetwar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>King George's Medical University</name>
      <address>
        <city>Lucknow</city>
        <state>Uttar Pradesh</state>
        <zip>226003</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shailendra Verma, DM, MD MBBS</last_name>
      <email>drspkgmu@rediffmail.com</email>
    </contact>
    <investigator>
      <last_name>Shailendra Verma, DM, MD, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Netaji Subhash Chandra Bose Cancer Research Institute</name>
      <address>
        <city>Kolkata</city>
        <state>West Bengal</state>
        <zip>700016</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ashis Mukhopadhyay, MD</last_name>
      <email>ncri.clinicalresearch@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ashis Mukhopadhyay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nil Ratan Sircar (NRS) Medical College</name>
      <address>
        <city>Kolkata</city>
        <state>West Bengal</state>
        <zip>700120</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tuphan Kanti Dolai, DM DNB MD MBBS</last_name>
      <email>tkdolai@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Tuphan Kanti Dolai, DM DNB MD MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>TATA Memorial Centre</name>
      <address>
        <city>Kolkata</city>
        <state>West Bengal</state>
        <zip>700160</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeevan Kumar, MBBS MD DNB</last_name>
      <email>jeevan.kumar@tmckolkata.com</email>
    </contact>
    <investigator>
      <last_name>Jeevan Kumar, MBBS MD DNB</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>All India Institute of Medical Sciences (AIIMS)</name>
      <address>
        <city>New Delhi</city>
        <zip>110029</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Atul Sharma, DM, MBBS, MD</last_name>
      <email>atul1@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Atul Sharma</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rajiv Gandhi Cancer Hospital</name>
      <address>
        <city>New Delhi</city>
        <zip>110085</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dinesh Bhurani, DM MD MBBS</last_name>
      <email>bhurani@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Dinesh Bhurani, DM MD MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barzilai Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <zip>7830604</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anatoly Nemets, MD</last_name>
      <email>anatolyn@bmc.gov.il</email>
    </contact>
    <investigator>
      <last_name>Anatoly Nemets, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rambam Health Care Campus</name>
      <address>
        <city>Haifa</city>
        <zip>3109601</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noa Lavi, MD</last_name>
      <email>n_lavi@rambam.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Noa Lavi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moshe Gatt</last_name>
      <email>Rmoshg@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>Moshe Gatt</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center</name>
      <address>
        <city>Petaẖ Tiqwa</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iuliana Vaxman, MD</last_name>
      <email>sjuliava@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Iuliana Vaxman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Maria of Terni</name>
      <address>
        <city>Terni</city>
        <state>Umbria</state>
        <zip>05100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Marina Liberati, M.D.</last_name>
      <email>marina.liberati@unipg.it</email>
    </contact>
    <investigator>
      <last_name>Anna Marina Liberati, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria Ospedali Riuniti</name>
      <address>
        <city>Ancona</city>
        <zip>60131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Massimo Offidani, Dr.</last_name>
      <email>massimo.offidani@ospedaliriuniti.marche.it</email>
    </contact>
    <investigator>
      <last_name>Massimo Offidani, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASST Papa Giovanni XXIII</name>
      <address>
        <city>Bergamo</city>
        <zip>24127</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Rambaldi, M.D.</last_name>
      <email>arambaldi@asst-pg23.it</email>
    </contact>
    <investigator>
      <last_name>Alessandro Rambaldi, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polyclinic S. Orsola-Malpighi, Department of Hematology, Oncology and Laboratory Medicine, Operative Unit of Hematology - Cavo</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Cavo, MD</last_name>
      <email>michele.cavo@unibo.it</email>
    </contact>
    <investigator>
      <last_name>Michele Cavo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Careggi, Department of Hematology</name>
      <address>
        <city>Florence</city>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Bosi, MD</last_name>
      <email>alberto.bosi@unifi.it</email>
    </contact>
    <investigator>
      <last_name>Alberto Bosi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital San Martino, IRCCA, Dept. of Integrative Cancer Therapies, Operative Unit of Clinical Hematology</name>
      <address>
        <city>Genoa</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Gobbi, MD</last_name>
      <email>gobbi@unige.it; marco.gobbi@unige.it</email>
    </contact>
    <investigator>
      <last_name>Marco Gobbi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Niguerda Ca Granda, Department of Hematology and Oncology, Hematology Unit</name>
      <address>
        <city>Milan</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Maria Cafro, MD</last_name>
      <email>annamaria.cafro@ospedaleniguarda.it</email>
    </contact>
    <investigator>
      <last_name>Anna Maria Cafro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Umberto I Polyclinic of Romw, Department of Cellular Biotechnology and Hematology, Hematology Center</name>
      <address>
        <city>Rome</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Roberto Foa, MD</last_name>
      <email>rfoa@bce.uniroma1.it</email>
    </contact>
    <investigator>
      <last_name>Roberto Foa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital San Giovanni Battista of Turin</name>
      <address>
        <city>Turin</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Bringhen, MD,PhD</last_name>
      <email>sara.bringhen@unito.it</email>
    </contact>
    <investigator>
      <last_name>Sara Bringhen, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jan Biziel University Hospital #2 in Bydgoszcz, Department of Hematology</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-168</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jaroslaw Czyz, MD PhD</last_name>
      <email>jczyz@onet.pl</email>
    </contact>
    <investigator>
      <last_name>Jaroslaw Czyz, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Independent Public Healthcare Facility Municipal Hospital Group in Chorzow, Department of Hematology</name>
      <address>
        <city>Chorzow</city>
        <zip>41-500</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Grosicki, MD PhD</last_name>
      <email>sgrosicki@wp.pl</email>
    </contact>
    <investigator>
      <last_name>Sebastian Grosicki, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital in Krakow, Teaching Unit of the Hematology Department</name>
      <address>
        <city>Krakow</city>
        <zip>31-501</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Artur Jurczyszyn, MD PhD</last_name>
      <email>artur@jurczyszyn.pl, mmjurczy@cyf-kr.edu.pl</email>
    </contact>
    <investigator>
      <last_name>Artur Jurczyszyn, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Independent Public Teaching Hospital No.1 in Lublin, Department of Hematology-Oncology and Bone Marrow Transplantation</name>
      <address>
        <city>Lublin</city>
        <zip>20-081</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marek Hus</last_name>
      <email>markhus@go2.pl</email>
    </contact>
    <investigator>
      <last_name>Marek Hus</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. John of Dukla Oncology Center of Lublin, Department of Hematology</name>
      <address>
        <city>Lublin</city>
        <zip>20-090</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krzysztof Giannopoulos, MD PhD</last_name>
      <email>Krzysztof.Giannopoulos@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Krzysztof Giannopoulos, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Military Institute of Medicine, Department of Internal Medicine and Hematology</name>
      <address>
        <city>Warsaw</city>
        <zip>04-141</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piotr Rzepecki, MD PhD</last_name>
      <email>przepecki@wim.mil.pl</email>
    </contact>
    <investigator>
      <last_name>Piotr Rzepecki, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nicolaus Copernicus Memorial Provincial Specialist Hospital in Lodz, Department of Hematology</name>
      <address>
        <city>Łódź</city>
        <zip>93-513</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robak, MD PhD</last_name>
      <email>robaktad@csk.umed.lodz.pl</email>
    </contact>
    <investigator>
      <last_name>Tadeusz Robak, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hyperclnical MedLife PDR Vulturului Brasov, Hematology Department</name>
      <address>
        <city>Braşov</city>
        <zip>500366</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mihaela Lazaroiu, MD</last_name>
      <email>ellalaz@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Mihaela Lazaroiu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Colentina Clinical Hospital, Department of Hematology</name>
      <address>
        <city>Bucharest</city>
        <zip>020125</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Viola Maria Popov, MD PhD</last_name>
      <email>violamariap@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Viola Maria Popov, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundeni Clinical Institute, Center for Hematology &amp; Bone Marrow Transplantation</name>
      <address>
        <city>Bucharest</city>
        <zip>022328</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Coriu, MD PhD</last_name>
      <email>daniel_coriu@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Daniel Coriu, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bucharest University Emergency Hospital, Department of Hematology</name>
      <address>
        <city>Bucharest</city>
        <zip>050098</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Horia Bumbea, MD PhD</last_name>
      <email>horiabum@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Horia Bumbea, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S.P. Botkin City Clinical Hospital</name>
      <address>
        <city>Moscow</city>
        <zip>125284</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nuriet Khuazheva, M.D.</last_name>
      <email>botkinhospital@yandex.ru</email>
    </contact>
    <investigator>
      <last_name>Nuriet Khuazheva, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>N.A. Semashko Central Clinical Hospital #2 under OJSC Russian Railways</name>
      <address>
        <city>Moscow</city>
        <zip>129128</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vadim Doronin, M.D.</last_name>
      <email>vadim_doronin@mail.ru</email>
    </contact>
    <investigator>
      <last_name>Vadim Doronin, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>First I.P. Pavlov State Medical University of St. Petersburg</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Boris Afanasyev, M.D., D.Med.Sci.</last_name>
      <email>bmt.lymphoma@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Boris Afanasyev, M.D., D.Med.Sci.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>V.A. Almazov North-West Federal Medical Research Center, Chemotherapy of Oncohematology Diseases and Bone Marrow Transplantation Department #1</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galina Salogub, M.D., PhD</last_name>
      <email>salogub@bk.ru</email>
    </contact>
    <investigator>
      <last_name>Galina Salogub, M.D., PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Center of Serbia, Clinic of Hematology</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jelena Bila, MD PhD</last_name>
      <email>jbila@yubc.net</email>
    </contact>
    <investigator>
      <last_name>Jelena Bila, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Oncology and Radiology of Serbia, Clinic of Medical Oncology</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zoran Milojevic, M.D.</last_name>
      <email>hematologija.zvezdara@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Zoran Milojevic, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Center Kragujevac, Clinic of Hematology</name>
      <address>
        <city>Kragujevac</city>
        <zip>34 000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Predrag Djurdjevic, MD PhD</last_name>
      <email>pdjurdjevic@sbb.rs</email>
    </contact>
    <investigator>
      <last_name>Predrag Djurdjevic, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Center Nis, Clinic of Hematology and Clinical Immunology</name>
      <address>
        <city>Nis</city>
        <zip>18 000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lana Macukanovic-Golubovic, MD PhD</last_name>
      <email>hematologijakcnis@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Lana Macukanovic-Golubovic, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Center of Vojvodina, Clinic of Hematology</name>
      <address>
        <city>Novi Sad</city>
        <zip>21 000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aleksandar Savic, M.D., PhD</last_name>
      <email>asavic@uns.ac.rs</email>
    </contact>
    <investigator>
      <last_name>Aleksandar Savic, M.D., PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of the Canary Islands</name>
      <address>
        <city>La Laguna</city>
        <state>Santa Cruz De Tenerife</state>
        <zip>38320</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel-Teodor Hernandez Garcia, MD</last_name>
      <email>mthernan@ull.es</email>
    </contact>
    <investigator>
      <last_name>Miguel-Teodor Hernandez Garcia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Catalan Institute of Oncology (ICO) Badalona</name>
      <address>
        <city>Badalona</city>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albert Oriol-Rocafiguera, MD, PhD</last_name>
      <email>aoriol@iconcologia.net</email>
    </contact>
    <contact_backup>
      <last_name>, MD, PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Albert Oriol-Rocafiguera, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mercedes Gironella, MD</last_name>
      <email>mgironel@vhebron.net</email>
    </contact>
    <investigator>
      <last_name>Mercedes Gironella, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital October 12, Department of Hematology</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joaquin Martinez-Lopes, MD, PhD</last_name>
      <email>jmarti01@med.ucm.es</email>
    </contact>
    <investigator>
      <last_name>Joaquin Martinez-Lopes, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Infanta Leonor, Department of Hematology</name>
      <address>
        <city>Madrid</city>
        <zip>28301</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Hernandez-Rivas, MD, PhD</last_name>
      <email>jahernandezr@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Jose Hernandez-Rivas, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Clinico Navarra, Pamplona</name>
      <address>
        <city>Pamplona</city>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Rodriguez Otero, MD, PhD</last_name>
      <phone>+34 948 255 400</phone>
      <email>paurodriguez@unav.es</email>
    </contact>
    <investigator>
      <last_name>Paula Rodriguez Otero, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Clinical Hospital of Salamanca, Department of Hematology</name>
      <address>
        <city>Salamanca</city>
        <zip>37007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Mateos, MD, PhD</last_name>
      <email>mvmateos@usal.es</email>
    </contact>
    <investigator>
      <last_name>Maria Mateos, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Virgen del Rocio (HUVR)</name>
      <address>
        <city>Seville</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesus Martin Sanchez, M.D.</last_name>
      <email>jesus.martin.sspa@juntadeandalucia.es</email>
    </contact>
    <investigator>
      <last_name>Jesus Martin Sanchez, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cherkasy Rgional Oncology Center, Regional Treatment and Diagnostic Hematology Center, Department of Hematology</name>
      <address>
        <city>Cherkasy</city>
        <zip>18009</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Halyna Pylypenko, M.D.</last_name>
      <email>pilipenko_g@ukr.net</email>
    </contact>
    <investigator>
      <last_name>Halyna Pylypenko, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dnipropetrovsk City Multispecialty Clinical Hospital #4, Regional Hematology Center</name>
      <address>
        <city>Dnipropetrovsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Polina Kaplan</last_name>
      <email>pkaplan@ukr.net</email>
    </contact>
    <investigator>
      <last_name>Polina Kaplan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BMT Kiev Center</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Irina Korenkova</last_name>
      <email>irina_br@mail.ru</email>
    </contact>
    <investigator>
      <last_name>Irina Korenkova</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kiev Cancer Institute</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Iryna Kryachok</last_name>
      <email>Irina.kryachok@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Iryna Kryachok</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Blood Pathology and Transfusion Medicine, Department of Hematology with Laboratory Group</name>
      <address>
        <city>Lviv</city>
        <zip>79044</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zvenyslava Maslyak, MD PhD DrMedSci</last_name>
      <email>zvenyslava_masliak@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Zvenyslava Maslyak, MD PhD DrMedSci</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vinnytsia M.I. Pyrohov Regional Clinical Hospital, Department of Hematology</name>
      <address>
        <city>Vinnytsia</city>
        <zip>21018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanna Oliynyk, M.D.</last_name>
      <email>oleyanna@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Hanna Oliynyk, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>O.F. Herbachevskyi Regional Clinical Hospital, Hematology Department with Intensive Therapy Wards</name>
      <address>
        <city>Zhytomyr</city>
        <zip>10008</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamila Lysa</last_name>
      <email>lysa_hemat_zhyt@ukr.net</email>
    </contact>
    <investigator>
      <last_name>Tamila Lysa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Belfast Heatlh &amp; Social Care Trust Belfast City Hospital</name>
      <address>
        <city>Belfast</city>
        <state>Northern Ireland</state>
        <zip>BT9 7AB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oonagh Sheehy, MBBCh MRCP FRCPath</last_name>
      <email>Oonagh.Sheehy@belfasttrust.hscni.net</email>
    </contact>
    <investigator>
      <last_name>Oonagh Sheehy, MBBCh MRCP FRCPath</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NHS Tayside Ninewells Hospital</name>
      <address>
        <city>Dundee</city>
        <state>Scotland</state>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gordon Marron, MRCP FRCPath</last_name>
      <email>gordonmarron@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Gordon Marron, MRCP FRCPath</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NHS Lothian Western General Hospital</name>
      <address>
        <city>Edinburgh</city>
        <state>Scotland</state>
        <zip>EH4 2XU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huw Roddie, MBChB, PhD, FRCPE, FRCPath</last_name>
      <email>huw.roddie@luht.scot.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Huw Roddie, MBChB, PhD, FRCPE, FRCPath</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiff &amp; Vale University Health Board University Hospital of Wales</name>
      <address>
        <city>Cardiff</city>
        <state>Wales</state>
        <zip>CF14 4XW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ceri Bygrave, MBBCh FRCPath</last_name>
      <email>Ceri.Bygrave@wales.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Ceri Bygrave, MBBCh FRCPath</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Birmingham NHS Foundation Trust Queen Elizabeth Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guy Pratt, MD, FRCPath, FRCP</last_name>
      <email>G.E.Pratt@bham.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Guy Pratt, MD, FRCPath, FRCP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Leeds Teaching Hospitals NHS Trust St. James University Hospital</name>
      <address>
        <city>Leeds</city>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gordon Cook</last_name>
      <email>g.cook@leeds.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Gordon Cook</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals of Leicester NHS Trust Royal Leicester Infirmary</name>
      <address>
        <city>Leicester</city>
        <zip>LE1 5WW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mamta Garg, MD MRCP FRCP MRCPath FRCPath</last_name>
      <email>mamta.garg@uhl-tr.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Mamta Garg, MD MRCP FRCP MRCPath FRCPath</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Liverpool &amp; Broadgreen University Hospital NHS Trust Royal Liverpool University Hospital</name>
      <address>
        <city>Liverpool</city>
        <zip>L7 8XP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Hawkins, MBBS MRCP FRCPath PhD</last_name>
      <email>stephen.hawkins@rlbuht.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Stephen Hawkins, MBBS MRCP FRCPath PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>London North West Healthcare NHS Trust Northwick Park Hospital</name>
      <address>
        <city>London</city>
        <zip>HA1 3UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charalampia Kyriakou, MD PhD</last_name>
      <email>c.kyriakou@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Charalampia Kyriakou, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University College London</name>
      <address>
        <city>London</city>
        <zip>NW3 2PF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ashutosh Wechalekar, MBBS MD FRCP FRCPath DM</last_name>
      <email>a.wechalekar@ucl.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Ashutosh Wechalekar, MBBS MD FRCP FRCPath DM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>King's College Hospital NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reuben Benjamin, MBBS, MRCP, FRCPath, PhD</last_name>
      <email>reubenbenjamin@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Reuben Benjamin, MBBS, MRCP, FRCPath, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Imperial College Healthcare NHS Trust Hammersmith Hospital</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Auner, MD, PhD</last_name>
      <email>holger.auner04@imperial.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Holger Auner, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Christie NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <zip>M20 4BX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jim Cavet, MBBS MRCP MRCPath PhD</last_name>
      <email>Jim.Cavet@christie.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Jim Cavet, MBBS MRCP MRCPath PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital</name>
      <address>
        <city>Newcastle Upon Tyne</city>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Graham Jackson, MD MRCP MRCPath FRCP FRCPath</last_name>
      <email>graham.jackson@ncl.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Graham Jackson, MD MRCP MRCPath FRCP FRCPath</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Royal Wolverhampton NHS Trust New Cross Hospital</name>
      <address>
        <city>Wolverhampton</city>
        <zip>WV10 0QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supratik Basu, MD MRCP MRCPath FRC FRCPath</last_name>
      <email>supratik.basu@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Supratik Basu, MD MRCP MRCPath FRC FRCPath</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Spain</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2017</study_first_submitted>
  <study_first_submitted_qc>April 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Relapsed or Refractory Multiple Myeloma</keyword>
  <keyword>RRMM</keyword>
  <keyword>Bortezomib</keyword>
  <keyword>Dexamethasone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Neoplasms, Plasma Cell</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Bortezomib</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

